The Johnson & Johnson COVID Vaccine Halt: Here's What Investors Need to Know

The Johnson & Johnson COVID Vaccine Halt: Here's What Investors Need to Know

Johnson & Johnson (NYSE: JNJ) has what many Americans want: a one-dose COVID-19 vaccine. The U.S. Food and Drug Administration (FDA) granted the company Emergency Use Authorization in late February. The FDA and the Centers for Disease Control and Prevention (CDC) recommended a pause in administration of the J&J vaccine after the occurrence of "rare and severe" blood clots in some people.